173 related articles for article (PubMed ID: 8749781)
1. Origins and clinical implications of aneuploidy in early bladder cancer.
Shackney SE; Berg G; Simon SR; Cohen J; Amina S; Pommersheim W; Yakulis R; Wang S; Uhl M; Smith CA
Cytometry; 1995 Dec; 22(4):307-16. PubMed ID: 8749781
[TBL] [Abstract][Full Text] [Related]
2. [DNA ploidy and cell cycle phase analysis with flow cytometry in bladder wash. Preliminary experience].
Rivas del Fresno M; Salas Bustamante A; Suárez González JA; Tardón García A; Sampedro Nuño A
Arch Esp Urol; 2000; 53(1):29-36. PubMed ID: 10730422
[TBL] [Abstract][Full Text] [Related]
3. Aneuploidy in breast cancer: a fluorescence in situ hybridization study.
Shackney SE; Singh SG; Yakulis R; Smith CA; Pollice AA; Petruolo S; Waggoner A; Hartsock RJ
Cytometry; 1995 Dec; 22(4):282-91. PubMed ID: 8749778
[TBL] [Abstract][Full Text] [Related]
4. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy analysis of invasive bladder cancer by flow cytometry.
Badalament RA; Smith JJ; Franklin GL; Drago JR
In Vivo; 1990; 4(4):269-72. PubMed ID: 2103372
[TBL] [Abstract][Full Text] [Related]
6. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
[TBL] [Abstract][Full Text] [Related]
7. Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Puntoni M; Zanardi S; Branchi D; Bruno S; Curotto A; Varaldo M; Bruzzi P; Decensi A
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):979-83. PubMed ID: 17507625
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometry in cancer of the bladder].
Chassevent A; Allain YM; Chautard D; Larra F; Lépinard V; Soret JY
Cancer Radiother; 1998 Apr; 2 Suppl 1():12s-15s. PubMed ID: 9749070
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic methods in the diagnosis of invasive bladder cancer.
Krause FS; Feil G; Zumbrägel A; Bichler KH
Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
11. [The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer].
Kawamura K; Ikeda R; Suzuki K
Hinyokika Kiyo; 2000 Jun; 46(6):377-83. PubMed ID: 10934605
[TBL] [Abstract][Full Text] [Related]
12. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
13. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
15. Flow and image cytometry for DNA analysis in bladder washings: improved concordance by using internal reference for flow.
Chabanas A; Rambeaud JJ; Seigneurin D; Fradet Y; Lawrence JJ; Faure G
Cytometry; 1993 Nov; 14(8):943-50. PubMed ID: 8287737
[TBL] [Abstract][Full Text] [Related]
16. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Miyakawa A; Tachibana M; Tazaki H
Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
19. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
[TBL] [Abstract][Full Text] [Related]
20. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
